Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-BEP vs BEP in Poor-prognosis NSGCT
NCT07847190Phase 2Recruiting
- Sponsor
- N.N. Blokhin Russian Cancer Research Center
- Start
- Oct 2024
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in non-seminomatous germ cell tumor (NSGCT), sponsored by N.N. Blokhin Russian Cancer Research Center. Started Oct 2024; status: recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
non-seminomatous germ cell tumor (NSGCT)
Beyond the preview
Go deeper on NCT07847190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07847190.